Sun Pharmaceutical (SUNPHARMA) — Related Party Transaction

Sun Pharmaceutical Industries Limited announced a related party transaction filing involving Taro Pharmaceuticals subsidiaries, seeking shareholder approval via e-voting from February 24 to March 25, 2025, for up to USD 890 million in funding, revenue, and business transfers. The transaction includes loans, distribution agreements, and potential business transfers between Taro entities and Sun Pharma, with arm's length remuneration and justification as part of group integration. Shareholders must register on www.evotingindia.com to participate, with voting results announced by March 27, 2025.

📄 View Original Announcement (PDF)

📊 Stock Analysis — SUNPHARMA ✨ Ask AI About This

About Sun Pharmaceutical Industries Limited (SUNPHARMA)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹4,50,643.09 Cr P/E: 41.3 ROE: 15.1% ROCE: 20.3%

View full SUNPHARMA stock details →

📡 Get AI alerts when SUNPHARMA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track SUNPHARMA — Free

💡 Ask AI about this filing

"How does this related party transaction affect Sun Pharmaceutical Industries Limited's outlook?" "What did Sun Pharmaceutical Industries Limited announce on 20 February 2025?" "Is this positive or negative for SUNPHARMA?"

Ask AI Free →

📊 More SUNPHARMA filings

See all SUNPHARMA filings →

🔥 Also filed on 20 February 2025

CIPLA Cipla Limited Announcement TATASTEEL Tata Steel Limited Announcement VEDL Vedanta Limited Corporate Action BAJFINANCE Bajaj Finance Limited Voting Results ICICIBANK ICICI Bank Limited Board Meeting TATACONSUM TATA CONSUMER PRODUCTS LIMITED Voting Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when SUNPHARMA files new disclosures

Track SUNPHARMA filings, board meetings, and corporate actions. Free email alerts at 5 PM.